New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
07:56 EDTBONEBacterin says study cites potential for OsteoSponge SC
Bacterin International announced that The Journal of Foot & Ankle Surgery has published a study on the "Role of Demineralized Allograft Subchondral Bone in the Treatment of Shoulder Lesions of the Talus: Clinical Results with Two-Year Follow-up." This study followed the use of OsteoSponge SC in the treatment of medial shoulder lesions of the talus, with positive clinical outcomes at 2 years post-op. The OsteoSponge SC procedure has the potential to address defects associated with subchondral bone pathology, which includes failed microfracture procedures and other treatment modalities. The total estimated US market for knee and ankle microfractures in 2014 is approximately 410,000 procedures. Bacterin is the only company in this market with a product specifically positioned to address repair of the subchondral bone in treating these defects, and has demonstrated clinical evidence to support the unique approach.
News For BONE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 27, 2015
19:03 EDTBONEBacterin to acquire X-spine Systems, change name of new company to Xtant Medical
Bacterin announced that it intends to purchase the outstanding shares of privately held X-spine Systems in exchange for approximately 4.24M shares of Bacterin common stock and approximately $60M in cash, subject to customary working capital adjustments, and including the extinguishment of approximately $13M of X-spine debt. The transaction will position the combined company as a comprehensive supplier for spine surgery procedures that offers both hardware and biologics through a more substantial national distribution footprint. Concurrent with the closing, Bacterin International Holdings, Inc. will change its name to Xtant Medical Holdings, Inc. Dr. David Kirschman, currently X-spine CEO, will join the management team and serve as EVP and Chief Scientific Officer of Xtant Medical Holdings, Inc. He will also be president of X-spine Systems, the hardware subsidiary. Dr. Kirschman will also be appointed to the Xtant Medical Holdings, Inc. board.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use